APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coccidiosis Vaccines in Chickens

Compare research editions
View pricing & licenses

Selected research

Industry Research

Coccidiosis Vaccines in Chickens Industry Research Report 2026

1 January 2026126 pages

Choose your research edition.

Industry ResearchCoccidiosis Vaccines in Chickens Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Coccidiosis Vaccines in Chickens Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Coccidiosis Vaccines in Chickens Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coccidiosis Vaccines in Chickens Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Coccidiosis Vaccines in Chickens Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Coccidiosis Vaccines in Chickens market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Coccidiosis Vaccines in Chickens is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Coccidiosis Vaccines in Chickens is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Coccidiosis Vaccines in Chickens is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Coccidiosis Vaccines in Chickens include Biopharm, Bioproperties, Boehringer Ingelheim, Ceva Santé Animale, HIPRA, Huvepharma, MSD Animal Health, Nisseiken and Vaxxinova, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Coccidiosis Vaccines in Chickens market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Coccidiosis Vaccines in Chickens Market by Company

Biopharm

Bioproperties

Boehringer Ingelheim

Ceva Santé Animale

HIPRA

Huvepharma

MSD Animal Health

Nisseiken

Vaxxinova

Foshan Standard Biotech

Hlinte

Qilu Qingda Bio-Pharmaceutical

Skystar Bio-pharm

Guangdong Winsun Bio-pharmaceutical

Coccidiosis Vaccines in Chickens Segment by Type

Attenuated Vaccines

Non-attenuated Vaccines

Coccidiosis Vaccines in Chickens Segment by Application

Layers

Turkeys

Broilers

Breeders

Coccidiosis Vaccines in Chickens Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coccidiosis Vaccines in Chickens market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coccidiosis Vaccines in Chickens and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coccidiosis Vaccines in Chickens.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Coccidiosis Vaccines in Chickens manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Coccidiosis Vaccines in Chickens by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Coccidiosis Vaccines in Chickens in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Coccidiosis Vaccines in Chickens Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Coccidiosis Vaccines in Chickens Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Coccidiosis Vaccines in Chickens Sales Market Share by Manufacturers (2021-2026) Table 8. Global Coccidiosis Vaccines in Chickens Revenue of Manufacturers (2021-2026) Table 9. Global Coccidiosis Vaccines in Chickens Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Coccidiosis Vaccines in Chickens Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Coccidiosis Vaccines in Chickens Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Coccidiosis Vaccines in Chickens, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Coccidiosis Vaccines in Chickens, Product Type & Application Table 14. Global Coccidiosis Vaccines in Chickens Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Coccidiosis Vaccines in Chickens by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Biopharm Company Information Table 19. Biopharm Business Overview Table 20. Biopharm Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Biopharm Coccidiosis Vaccines in Chickens Product Portfolio Table 22. Biopharm Recent Developments Table 23. Bioproperties Company Information Table 24. Bioproperties Business Overview Table 25. Bioproperties Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Bioproperties Coccidiosis Vaccines in Chickens Product Portfolio Table 27. Bioproperties Recent Developments Table 28. Boehringer Ingelheim Company Information Table 29. Boehringer Ingelheim Business Overview Table 30. Boehringer Ingelheim Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Boehringer Ingelheim Coccidiosis Vaccines in Chickens Product Portfolio Table 32. Boehringer Ingelheim Recent Developments Table 33. Ceva Santé Animale Company Information Table 34. Ceva Santé Animale Business Overview Table 35. Ceva Santé Animale Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Ceva Santé Animale Coccidiosis Vaccines in Chickens Product Portfolio Table 37. Ceva Santé Animale Recent Developments Table 38. HIPRA Company Information Table 39. HIPRA Business Overview Table 40. HIPRA Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. HIPRA Coccidiosis Vaccines in Chickens Product Portfolio Table 42. HIPRA Recent Developments Table 43. Huvepharma Company Information Table 44. Huvepharma Business Overview Table 45. Huvepharma Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Huvepharma Coccidiosis Vaccines in Chickens Product Portfolio Table 47. Huvepharma Recent Developments Table 48. MSD Animal Health Company Information Table 49. MSD Animal Health Business Overview Table 50. MSD Animal Health Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. MSD Animal Health Coccidiosis Vaccines in Chickens Product Portfolio Table 52. MSD Animal Health Recent Developments Table 53. Nisseiken Company Information Table 54. Nisseiken Business Overview Table 55. Nisseiken Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Nisseiken Coccidiosis Vaccines in Chickens Product Portfolio Table 57. Nisseiken Recent Developments Table 58. Vaxxinova Company Information Table 59. Vaxxinova Business Overview Table 60. Vaxxinova Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Vaxxinova Coccidiosis Vaccines in Chickens Product Portfolio Table 62. Vaxxinova Recent Developments Table 63. Foshan Standard Biotech Company Information Table 64. Foshan Standard Biotech Business Overview Table 65. Foshan Standard Biotech Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Foshan Standard Biotech Coccidiosis Vaccines in Chickens Product Portfolio Table 67. Foshan Standard Biotech Recent Developments Table 68. Hlinte Company Information Table 69. Hlinte Business Overview Table 70. Hlinte Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hlinte Coccidiosis Vaccines in Chickens Product Portfolio Table 72. Hlinte Recent Developments Table 73. Qilu Qingda Bio-Pharmaceutical Company Information Table 74. Qilu Qingda Bio-Pharmaceutical Business Overview Table 75. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio Table 77. Qilu Qingda Bio-Pharmaceutical Recent Developments Table 78. Skystar Bio-pharm Company Information Table 79. Skystar Bio-pharm Business Overview Table 80. Skystar Bio-pharm Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Skystar Bio-pharm Coccidiosis Vaccines in Chickens Product Portfolio Table 82. Skystar Bio-pharm Recent Developments Table 83. Guangdong Winsun Bio-pharmaceutical Company Information Table 84. Guangdong Winsun Bio-pharmaceutical Business Overview Table 85. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio Table 87. Guangdong Winsun Bio-pharmaceutical Recent Developments Table 88. Global Coccidiosis Vaccines in Chickens Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Coccidiosis Vaccines in Chickens Sales by Region (2021-2026) & (K Units) Table 90. Global Coccidiosis Vaccines in Chickens Sales Market Share by Region (2021-2026) Table 91. Global Coccidiosis Vaccines in Chickens Sales by Region (2027-2032) & (K Units) Table 92. Global Coccidiosis Vaccines in Chickens Sales Market Share by Region (2027-2032) Table 93. Global Coccidiosis Vaccines in Chickens Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Region (2021-2026) Table 95. Global Coccidiosis Vaccines in Chickens Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Region (2027-2032) Table 97. North America Coccidiosis Vaccines in Chickens Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Coccidiosis Vaccines in Chickens Sales by Country (2021-2026) & (K Units) Table 99. North America Coccidiosis Vaccines in Chickens Sales by Country (2027-2032) & (K Units) Table 100. North America Coccidiosis Vaccines in Chickens Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Coccidiosis Vaccines in Chickens Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Coccidiosis Vaccines in Chickens Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Coccidiosis Vaccines in Chickens Sales by Country (2021-2026) & (K Units) Table 104. Europe Coccidiosis Vaccines in Chickens Sales by Country (2027-2032) & (K Units) Table 105. Europe Coccidiosis Vaccines in Chickens Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Coccidiosis Vaccines in Chickens Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Coccidiosis Vaccines in Chickens Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Coccidiosis Vaccines in Chickens Sales by Country (2021-2026) & (K Units) Table 109. Asia Pacific Coccidiosis Vaccines in Chickens Sales by Country (2027-2032) & (K Units) Table 110. Asia Pacific Coccidiosis Vaccines in Chickens Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Coccidiosis Vaccines in Chickens Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Coccidiosis Vaccines in Chickens Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Coccidiosis Vaccines in Chickens Sales by Country (2021-2026) & (K Units) Table 114. South America Coccidiosis Vaccines in Chickens Sales by Country (2027-2032) & (K Units) Table 115. South America Coccidiosis Vaccines in Chickens Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Coccidiosis Vaccines in Chickens Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Coccidiosis Vaccines in Chickens Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Coccidiosis Vaccines in Chickens Sales by Country (2021-2026) & (K Units) Table 119. Middle East and Africa Coccidiosis Vaccines in Chickens Sales by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Coccidiosis Vaccines in Chickens Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Coccidiosis Vaccines in Chickens Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Coccidiosis Vaccines in Chickens Sales by Type (2021-2026) & (K Units) Table 123. Global Coccidiosis Vaccines in Chickens Sales by Type (2027-2032) & (K Units) Table 124. Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2021-2026) Table 125. Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2027-2032) Table 126. Global Coccidiosis Vaccines in Chickens Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Coccidiosis Vaccines in Chickens Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2021-2026) Table 129. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2027-2032) Table 130. Global Coccidiosis Vaccines in Chickens Price by Type (2021-2026) & (US$/Unit) Table 131. Global Coccidiosis Vaccines in Chickens Price by Type (2027-2032) & (US$/Unit) Table 132. Global Coccidiosis Vaccines in Chickens Sales by Application (2021-2026) & (K Units) Table 133. Global Coccidiosis Vaccines in Chickens Sales by Application (2027-2032) & (K Units) Table 134. Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2021-2026) Table 135. Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2027-2032) Table 136. Global Coccidiosis Vaccines in Chickens Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Coccidiosis Vaccines in Chickens Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2021-2026) Table 139. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2027-2032) Table 140. Global Coccidiosis Vaccines in Chickens Price by Application (2021-2026) & (US$/Unit) Table 141. Global Coccidiosis Vaccines in Chickens Price by Application (2027-2032) & (US$/Unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Coccidiosis Vaccines in Chickens Distributors List Table 145. Coccidiosis Vaccines in Chickens Customers List Table 146. Coccidiosis Vaccines in Chickens Industry Trends Table 147. Coccidiosis Vaccines in Chickens Industry Drivers Table 148. Coccidiosis Vaccines in Chickens Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Coccidiosis Vaccines in Chickens Product Image Figure 5. Global Coccidiosis Vaccines in Chickens Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Coccidiosis Vaccines in Chickens Market Size (2021-2032) & (US$ Million) Figure 7. Global Coccidiosis Vaccines in Chickens Sales (2021-2032) & (K Units) Figure 8. Global Coccidiosis Vaccines in Chickens Average Price (US$/Unit) & (2021-2032) Figure 9. Attenuated Vaccines Product Image Figure 10. Non-attenuated Vaccines Product Image Figure 11. Layers Product Image Figure 12. Turkeys Product Image Figure 13. Broilers Product Image Figure 14. Breeders Product Image Figure 15. Global Coccidiosis Vaccines in Chickens Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Coccidiosis Vaccines in Chickens, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Coccidiosis Vaccines in Chickens Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Coccidiosis Vaccines in Chickens Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Coccidiosis Vaccines in Chickens Sales by Region in 2025 Figure 21. Global Coccidiosis Vaccines in Chickens Revenue by Region in 2025 Figure 22. North America Coccidiosis Vaccines in Chickens Market Size by Country in 2025 Figure 23. North America Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021-2032) Figure 24. North America Coccidiosis Vaccines in Chickens Revenue Market Share by Country (2021-2032) Figure 25. United States Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Coccidiosis Vaccines in Chickens Market Size by Country in 2025 Figure 28. Europe Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021-2032) Figure 29. Europe Coccidiosis Vaccines in Chickens Revenue Market Share by Country (2021-2032) Figure 30. Germany Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific Coccidiosis Vaccines in Chickens Market Size by Country in 2025 Figure 36. Asia Pacific Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific Coccidiosis Vaccines in Chickens Revenue Market Share by Country (2021-2032) Figure 38. China Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America Coccidiosis Vaccines in Chickens Market Size by Country in 2025 Figure 47. South America Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021-2032) Figure 48. South America Coccidiosis Vaccines in Chickens Revenue Market Share by Country (2021-2032) Figure 49. Mexico Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Coccidiosis Vaccines in Chickens Market Size by Country in 2025 Figure 53. Middle East and Africa Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Coccidiosis Vaccines in Chickens Revenue Market Share by Country (2021-2032) Figure 55. Turkey Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Coccidiosis Vaccines in Chickens Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2021-2032) Figure 59. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2021-2032) Figure 60. Global Coccidiosis Vaccines in Chickens Price (US$/Unit) by Type (2021-2032) Figure 61. Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2021-2032) Figure 62. Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2021-2032) Figure 63. Global Coccidiosis Vaccines in Chickens Price (US$/Unit) by Application (2021-2032) Figure 64. Coccidiosis Vaccines in Chickens Value Chain Figure 65. Coccidiosis Vaccines in Chickens Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Coccidiosis Vaccines in Chickens Industry Opportunities and Challenges

Scope & coverage.

Types
  • Attenuated Vaccines
  • Non-attenuated Vaccines
Applications
  • Layers
  • Turkeys
  • Broilers
  • Breeders
Companies covered
  • Biopharm
  • Bioproperties
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • HIPRA
  • Huvepharma
  • MSD Animal Health
  • Nisseiken
  • Vaxxinova
  • Foshan Standard Biotech
  • Hlinte
  • Qilu Qingda Bio-Pharmaceutical
  • Skystar Bio-pharm
  • Guangdong Winsun Bio-pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Coccidiosis Vaccines in Chickens Market Size (2021-2032)
  4. 2.2.2 Global Coccidiosis Vaccines in Chickens Sales (2021-2032)
  5. 2.2.3 Global Coccidiosis Vaccines in Chickens Market Average Price (2021-2032)
  6. 2.3 Coccidiosis Vaccines in Chickens by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Attenuated Vaccines
  9. 2.3.3 Non-attenuated Vaccines
  10. 2.4 Coccidiosis Vaccines in Chickens by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Layers
  13. 2.4.3 Turkeys
  14. 2.4.4 Broilers
  15. 2.4.5 Breeders
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Coccidiosis Vaccines in Chickens Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Coccidiosis Vaccines in Chickens Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Coccidiosis Vaccines in Chickens Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Coccidiosis Vaccines in Chickens Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Coccidiosis Vaccines in Chickens Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Coccidiosis Vaccines in Chickens, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Coccidiosis Vaccines in Chickens, Product Type & Application
  8. 3.8 Global Manufacturers of Coccidiosis Vaccines in Chickens, Established Date
  9. 3.9 Global Coccidiosis Vaccines in Chickens Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Biopharm
  2. 4.1.1 Biopharm Company Information
  3. 4.1.2 Biopharm Business Overview
  4. 4.1.3 Biopharm Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Biopharm Coccidiosis Vaccines in Chickens Product Portfolio
  6. 4.1.5 Biopharm Recent Developments
  7. 4.2 Bioproperties
  8. 4.2.1 Bioproperties Company Information
  9. 4.2.2 Bioproperties Business Overview
  10. 4.2.3 Bioproperties Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Bioproperties Coccidiosis Vaccines in Chickens Product Portfolio
  12. 4.2.5 Bioproperties Recent Developments
  13. 4.3 Boehringer Ingelheim
  14. 4.3.1 Boehringer Ingelheim Company Information
  15. 4.3.2 Boehringer Ingelheim Business Overview
  16. 4.3.3 Boehringer Ingelheim Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Boehringer Ingelheim Coccidiosis Vaccines in Chickens Product Portfolio
  18. 4.3.5 Boehringer Ingelheim Recent Developments
  19. 4.4 Ceva Santé Animale
  20. 4.4.1 Ceva Santé Animale Company Information
  21. 4.4.2 Ceva Santé Animale Business Overview
  22. 4.4.3 Ceva Santé Animale Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Ceva Santé Animale Coccidiosis Vaccines in Chickens Product Portfolio
  24. 4.4.5 Ceva Santé Animale Recent Developments
  25. 4.5 HIPRA
  26. 4.5.1 HIPRA Company Information
  27. 4.5.2 HIPRA Business Overview
  28. 4.5.3 HIPRA Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 HIPRA Coccidiosis Vaccines in Chickens Product Portfolio
  30. 4.5.5 HIPRA Recent Developments
  31. 4.6 Huvepharma
  32. 4.6.1 Huvepharma Company Information
  33. 4.6.2 Huvepharma Business Overview
  34. 4.6.3 Huvepharma Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Huvepharma Coccidiosis Vaccines in Chickens Product Portfolio
  36. 4.6.5 Huvepharma Recent Developments
  37. 4.7 MSD Animal Health
  38. 4.7.1 MSD Animal Health Company Information
  39. 4.7.2 MSD Animal Health Business Overview
  40. 4.7.3 MSD Animal Health Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 MSD Animal Health Coccidiosis Vaccines in Chickens Product Portfolio
  42. 4.7.5 MSD Animal Health Recent Developments
  43. 4.8 Nisseiken
  44. 4.8.1 Nisseiken Company Information
  45. 4.8.2 Nisseiken Business Overview
  46. 4.8.3 Nisseiken Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Nisseiken Coccidiosis Vaccines in Chickens Product Portfolio
  48. 4.8.5 Nisseiken Recent Developments
  49. 4.9 Vaxxinova
  50. 4.9.1 Vaxxinova Company Information
  51. 4.9.2 Vaxxinova Business Overview
  52. 4.9.3 Vaxxinova Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Vaxxinova Coccidiosis Vaccines in Chickens Product Portfolio
  54. 4.9.5 Vaxxinova Recent Developments
  55. 4.10 Foshan Standard Biotech
  56. 4.10.1 Foshan Standard Biotech Company Information
  57. 4.10.2 Foshan Standard Biotech Business Overview
  58. 4.10.3 Foshan Standard Biotech Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Foshan Standard Biotech Coccidiosis Vaccines in Chickens Product Portfolio
  60. 4.10.5 Foshan Standard Biotech Recent Developments
  61. 4.11 Hlinte
  62. 4.11.1 Hlinte Company Information
  63. 4.11.2 Hlinte Business Overview
  64. 4.11.3 Hlinte Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hlinte Coccidiosis Vaccines in Chickens Product Portfolio
  66. 4.11.5 Hlinte Recent Developments
  67. 4.12 Qilu Qingda Bio-Pharmaceutical
  68. 4.12.1 Qilu Qingda Bio-Pharmaceutical Company Information
  69. 4.12.2 Qilu Qingda Bio-Pharmaceutical Business Overview
  70. 4.12.3 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio
  72. 4.12.5 Qilu Qingda Bio-Pharmaceutical Recent Developments
  73. 4.13 Skystar Bio-pharm
  74. 4.13.1 Skystar Bio-pharm Company Information
  75. 4.13.2 Skystar Bio-pharm Business Overview
  76. 4.13.3 Skystar Bio-pharm Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Skystar Bio-pharm Coccidiosis Vaccines in Chickens Product Portfolio
  78. 4.13.5 Skystar Bio-pharm Recent Developments
  79. 4.14 Guangdong Winsun Bio-pharmaceutical
  80. 4.14.1 Guangdong Winsun Bio-pharmaceutical Company Information
  81. 4.14.2 Guangdong Winsun Bio-pharmaceutical Business Overview
  82. 4.14.3 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio
  84. 4.14.5 Guangdong Winsun Bio-pharmaceutical Recent Developments
5 Global Coccidiosis Vaccines in Chickens Market Scenario by Region
  1. 5.1 Global Coccidiosis Vaccines in Chickens Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Coccidiosis Vaccines in Chickens Sales by Region: 2021-2032
  3. 5.2.1 Global Coccidiosis Vaccines in Chickens Sales by Region: 2021-2026
  4. 5.2.2 Global Coccidiosis Vaccines in Chickens Sales by Region: 2027-2032
  5. 5.3 Global Coccidiosis Vaccines in Chickens Revenue by Region: 2021-2032
  6. 5.3.1 Global Coccidiosis Vaccines in Chickens Revenue by Region: 2021-2026
  7. 5.3.2 Global Coccidiosis Vaccines in Chickens Revenue by Region: 2027-2032
  8. 5.4 North America Coccidiosis Vaccines in Chickens Market Facts & Figures by Country
  9. 5.4.1 North America Coccidiosis Vaccines in Chickens Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Coccidiosis Vaccines in Chickens Sales by Country (2021-2032)
  11. 5.4.3 North America Coccidiosis Vaccines in Chickens Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Coccidiosis Vaccines in Chickens Market Facts & Figures by Country
  15. 5.5.1 Europe Coccidiosis Vaccines in Chickens Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Coccidiosis Vaccines in Chickens Sales by Country (2021-2032)
  17. 5.5.3 Europe Coccidiosis Vaccines in Chickens Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Coccidiosis Vaccines in Chickens Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Coccidiosis Vaccines in Chickens Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Coccidiosis Vaccines in Chickens Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Coccidiosis Vaccines in Chickens Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Coccidiosis Vaccines in Chickens Market Facts & Figures by Country
  35. 5.7.1 South America Coccidiosis Vaccines in Chickens Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Coccidiosis Vaccines in Chickens Sales by Country (2021-2032)
  37. 5.7.3 South America Coccidiosis Vaccines in Chickens Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Coccidiosis Vaccines in Chickens Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Coccidiosis Vaccines in Chickens Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Coccidiosis Vaccines in Chickens Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Coccidiosis Vaccines in Chickens Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Coccidiosis Vaccines in Chickens Sales by Type (2021-2032)
  2. 6.1.1 Global Coccidiosis Vaccines in Chickens Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Coccidiosis Vaccines in Chickens Sales Market Share by Type (2021-2032)
  4. 6.2 Global Coccidiosis Vaccines in Chickens Revenue by Type (2021-2032)
  5. 6.2.1 Global Coccidiosis Vaccines in Chickens Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Coccidiosis Vaccines in Chickens Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Coccidiosis Vaccines in Chickens Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Coccidiosis Vaccines in Chickens Sales by Application (2021-2032)
  2. 7.1.1 Global Coccidiosis Vaccines in Chickens Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Coccidiosis Vaccines in Chickens Sales Market Share by Application (2021-2032)
  4. 7.2 Global Coccidiosis Vaccines in Chickens Revenue by Application (2021-2032)
  5. 7.2.1 Global Coccidiosis Vaccines in Chickens Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Coccidiosis Vaccines in Chickens Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Coccidiosis Vaccines in Chickens Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Coccidiosis Vaccines in Chickens Value Chain Analysis
  2. 8.1.1 Coccidiosis Vaccines in Chickens Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Coccidiosis Vaccines in Chickens Production Mode & Process
  5. 8.2 Coccidiosis Vaccines in Chickens Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Coccidiosis Vaccines in Chickens Distributors
  8. 8.2.3 Coccidiosis Vaccines in Chickens Customers
9 Global Coccidiosis Vaccines in Chickens Analyzing Market Dynamics
  1. 9.1 Coccidiosis Vaccines in Chickens Industry Trends
  2. 9.2 Coccidiosis Vaccines in Chickens Industry Drivers
  3. 9.3 Coccidiosis Vaccines in Chickens Industry Opportunities and Challenges
  4. 9.4 Coccidiosis Vaccines in Chickens Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst